Huimin Hu Selected Research

Urea (Carbamide)

11/2016	Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
5/2011	Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huimin Hu Research Topics

Disease

35	Neoplasms (Cancer) 12/2023 - 12/2010
20	Glioma (Gliomas) 03/2021 - 01/2015
8	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2024 - 04/2002
7	Infections 01/2024 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2019
4	Hepatoblastoma 01/2024 - 01/2019
4	Pain (Aches) 12/2023 - 10/2019
4	Mucolipidoses (Sialidosis) 11/2023 - 02/2010
4	Inflammation (Inflammations) 11/2020 - 11/2016
3	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 01/2014
3	Margins of Excision 06/2023 - 02/2015
3	Rhabdomyosarcoma 01/2022 - 01/2020
3	Neuraminidase deficiency with beta-galactosidase deficiency 12/2021 - 02/2012
3	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2016 - 12/2010
3	Body Weight (Weight, Body) 11/2016 - 02/2010
2	Glycoprotein Storage Disease 11/2023 - 01/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 12/2017
2	Disease Progression 01/2020 - 01/2016
2	Brain Neoplasms (Brain Tumor) 12/2019 - 01/2015
2	Wounds and Injuries (Trauma) 02/2019 - 05/2016
2	Carcinogenesis 01/2017 - 03/2015
2	Proteinuria 05/2011 - 02/2010
2	Chronic Renal Insufficiency 05/2011 - 02/2010
2	Fibrosis (Cirrhosis) 05/2011 - 02/2010
1	COVID-19 01/2024
1	Plasmacytoma 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 12/2023
1	Neutropenia 12/2023
1	Febrile Neutropenia 12/2023
1	Disease Resistance 11/2023
1	Osteoporosis 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Bone Diseases (Bone Disease) 01/2023
1	Diarrhea 09/2022
1	Pulmonary Hypertension 04/2022
1	Right Ventricular Dysfunction 04/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2022
1	Brain Ischemia (Cerebral Ischemia) 04/2022
1	Ischemic Stroke 04/2022
1	Osteoarthritis 03/2022
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 03/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Myeloid Sarcoma (Chloroma) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2010
7	Messenger RNA (mRNA)IBA 11/2019 - 12/2014
5	Neuraminidase (Sialidase)IBA 11/2023 - 02/2010
5	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2015
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2019 - 01/2015
4	GalactosidasesIBA 04/2024 - 03/2021
4	MicroRNAs (MicroRNA)IBA 11/2023 - 12/2017
4	5'-deoxy-5'-phosphonomethyladenosine phosphateIBA 12/2021 - 02/2012
3	Cathepsin AIBA 12/2021 - 02/2012
3	LigandsIBA 01/2021 - 03/2015
3	Phosphotransferases (Kinase)IBA 01/2021 - 03/2015
3	EnzymesIBA 11/2020 - 04/2002
3	Biomarkers (Surrogate Marker)IBA 07/2020 - 12/2014
2	AntibodiesIBA 01/2024 - 01/2017
2	Long Noncoding RNAIBA 01/2024 - 10/2019
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2024 - 01/2021
2	eprenetapoptIBA 04/2023 - 01/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2021
2	Ifosfamide FDA LinkGeneric 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2018
2	CateninsIBA 01/2021 - 12/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2019 - 03/2015
2	ErbB Receptors (EGF Receptor)IBA 12/2019 - 04/2015
2	Small Interfering RNA (siRNA)IBA 11/2019 - 12/2014
2	HomocysteineIBA 02/2019 - 05/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2019
2	Immune Checkpoint InhibitorsIBA 09/2018 - 01/2017
2	Urea (Carbamide)FDA LinkGeneric 11/2016 - 05/2011
2	NitrogenIBA 11/2016 - 05/2011
2	CytokinesIBA 01/2015 - 01/2014
2	Dietary ProteinsIBA 05/2011 - 02/2010
2	Serum AlbuminIBA 05/2011 - 02/2010
1	Immunoglobulin G (IgG)IBA 01/2024
1	AntigensIBA 12/2023
1	Chimeric Antigen ReceptorsIBA 12/2023
1	CholesterolIBA 12/2023
1	pegfilgrastim (Neulasta)FDA Link 12/2023
1	Analgesics (Analgesic Drugs)IBA 12/2023
1	OligosaccharidesIBA 11/2023
1	Glycoproteins (Glycoprotein)IBA 11/2023
1	Fetal Proteins (Fetoprotein)IBA 06/2023
1	obacunoneIBA 01/2023
1	IntegrinsIBA 01/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2022
1	Glucose (Dextrose)FDA LinkGeneric 04/2022
1	Oxygen (Dioxygen)IBA 04/2022
1	A73025IBA 03/2022
1	Alkylating AgentsIBA 01/2022

Therapy/Procedure

11	Therapeutics 12/2023 - 02/2010
10	Drug Therapy (Chemotherapy) 01/2024 - 01/2009
4	Immunotherapy 01/2021 - 01/2017
2	Neoadjuvant Therapy 01/2024 - 06/2023
2	Radiotherapy 01/2022 - 01/2020
1	Treatment Delay 12/2023